SBIO PE Ratio & Valuation, Is SBIO Overvalued

Performance Decomposition

AI Analysis

Market capitalization of SBIO increased by 0.00% over the past 1 year(s). The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.

The secondary factor is the Unknown, contributed 0.00% to the performance.

Overall, the performance of SBIO in the past 1 year(s) is driven by Unknown.

People Also Watch

Frequently Asked Questions

Is SBIO currently overvalued or undervalued?

ALPS Medical Breakthroughs ETF (SBIO) is now in the Fair zone, suggesting that its current forward PS ratio of NaN is considered Fairly compared with the five-year average of --. The fair price of ALPS Medical Breakthroughs ETF (SBIO) is between -- to -- according to relative valuation method.

What is ALPS Medical Breakthroughs ETF (SBIO) fair value?

SBIO's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. The fair price of ALPS Medical Breakthroughs ETF (SBIO) is between -- to -- according to relative valuation method.

How does SBIO's valuation metrics compare to the industry average?

The average P/S ratio for SBIO's competitors is 0.00, providing a benchmark for relative valuation. ALPS Medical Breakthroughs ETF Corp (SBIO) exhibits a P/S ratio of --, which is 0% above the industry average. Given its robust revenue growth of 0%, this premium appears unsustainable.

What is the current P/B ratio for ALPS Medical Breakthroughs ETF (SBIO) as of Mar 25 2026?

As of Mar 25 2026, ALPS Medical Breakthroughs ETF (SBIO) has a P/B ratio of NaN. This indicates that the market values SBIO at NaN times its book value.

What is the current FCF Yield for ALPS Medical Breakthroughs ETF (SBIO) as of Mar 25 2026?

As of Mar 25 2026, ALPS Medical Breakthroughs ETF (SBIO) has a FCF Yield of NaN%. This means that for every dollar of ALPS Medical Breakthroughs ETF's market capitalization, the company generates NaN cents in free cash flow.

What is the current Forward P/E ratio for ALPS Medical Breakthroughs ETF (SBIO) as of Mar 25 2026?

As of Mar 25 2026, ALPS Medical Breakthroughs ETF (SBIO) has a Forward P/E ratio of NaN. This means the market is willing to pay $NaN for every dollar of ALPS Medical Breakthroughs ETF's expected earnings over the next 12 months.

What is the current Forward P/S ratio for ALPS Medical Breakthroughs ETF (SBIO) as of Mar 25 2026?

As of Mar 25 2026, ALPS Medical Breakthroughs ETF (SBIO) has a Forward P/S ratio of NaN. This means the market is valuing SBIO at $NaN for every dollar of expected revenue over the next 12 months.

SBIO Valuation